According to Mallinckrodt Pharmaceuticals
's latest financial reports the company has โฌ0.43 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | โฌ0.38 B | -67.86% |
2021-12-31 | โฌ1.18 B | 36.44% |
2020-12-31 | โฌ0.87 B | 23.29% |
2019-12-31 | โฌ0.70 B | 131.49% |
2018-12-31 | โฌ0.30 B | -70.98% |
2017-12-31 | โฌ1.05 B | |
2016-09-30 | โฌ0.25 B | -23.09% |
2015-09-30 | โฌ0.32 B | -41.71% |
2014-09-30 | โฌ0.55 B | 173.2% |
2013-09-30 | โฌ0.20 B |